跳至主要内容
临床试验/NL-OMON41650
NL-OMON41650尚未招募不适用

A phase I study on Dendritic cells loaded with allogeneous cell lysate (Alloys) in patients with mesothelioma as maintenance treatment (AlloDen) - AlloDen1

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 18 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
18

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • The study population consists of adult patients with malignant mesothelioma who have been or have not been treated with chemotherapy. Patients treated with chemotherapy must not experience progressive disease during chemotherapy. In selected cases with low disease burden as determined by the multidisciplinary tumor board of Erasmus MC Rotterdam, patients can be included after diagnosis before any treatment.

排除标准

  • patients with mesothelioma progressive after chemotherapy

研究者

相似试验